# Humacyte receives $3.4M DoD contract for vascular trauma trial

Humacyte announced a $3.4 million U.S. Department of Defense contract to support additional clinical sites for its Phase II vascular trauma trial in the U.S.

- Type: Contract
- Announced: 2017-10-02
- Where: United States
- Value: $3.40M
- Status: completed
- Products: human acellular vessel (Humacyl)
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [U.S. Department of Defense](https://endata.com/companies/4836.md) (customer)
- [Humacyte](https://endata.com/companies/27334.md) (supplier)

## Sources

- [massdevice.com](https://www.massdevice.com/cardinal-health-millions-dod-contracts/), 2017-10-02: "Humacyte today announced a $3.4 million D0D contract to help support additional clinical sites for Humacyte’s Phase II vascular trauma trial."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.